翻訳と辞書 Words near each other ・ Trois grandes études ・ Trois jours chez ma mère ・ Trois milliards sans ascenseur ・ Trois morceaux dans le genre pathétique ・ Trois mouvements de Petrouchka ・ Trois mouvements perpétuels ・ Trois mélodies, Op.7 (Fauré) ・ Trois nouvelles études ・ Trois novelettes (Poulenc) ・ Trois petites liturgies de la présence divine ・ Trois petites pièces montées ・ Trois Pistoles railway station ・ Trois Pitons ・ Troglav (Bosnia and Herzegovina) ・ Troglav (Serbia) ・ Troglitazone ・ Trogloagonum ・ Troglocambarus ・ Troglocaris ・ Troglocaris anophthalmus ・ Troglocimmerites ・ Trogloconcha ・ Trogloconcha christinae ・ Trogloconcha lamellinodosa ・ Trogloconcha lozoueti ・ Trogloconcha ohashii ・ Trogloconcha tesselata ・ Troglocoptes ・ Troglocyclocheilus khammouanensis ・ Troglodytae Dictionary Lists mini英和辞書 mini和英辞書 Webster 1913 Latin-English FOLDOC Wikipedia English ウィキペディア

翻訳と辞書　辞書検索 [ 開発暫定版 ] スポンサード リンク Troglitazone ： ウィキペディア英語版 Troglitazone Troglitazone (Rezulin, Resulin, Romozin, Noscal) is an antidiabetic and anti-inflammatory drug, and a member of the drug class of the thiazolidinediones. It was prescribed for patients with diabetes mellitus type 2. It was developed by Daiichi Sankyo (Japan). In the United States, it was introduced and manufactured by Parke-Davis in the late 1990s, but turned out to be associated with an idiosyncratic reaction leading to drug-induced hepatitis. One F.D.A. medical officer evaluating troglitazone, John Gueriguian, did not recommend its approval due to potential high liver toxicity,〔(Retired Drugs: Failed Blockbusters, Homicidal Tampering, Fatal Oversights ), wired.com〕 but a full panel of experts approved it in January 1997. Once the prevalence of adverse liver effects became known, troglitazone was withdrawn from the British market in December 1997, from the United States market in 2000, and from the Japanese market soon afterwards. It did not get approval in the rest of Europe. ==Mechanism of action== Troglitazone, like the other thiazolidinediones (pioglitazone and rosiglitazone), works by activating peroxisome proliferator-activated receptors (PPARs). Troglitazone is a ligand to both PPARα and – more strongly – PPARγ. Troglitazone also contains an α-tocopheroyl moiety, potentially giving it vitamin E-like activity in addition to its PPAR activation. It has been shown to reduce inflammation: troglitazone use was associated with a decrease of nuclear factor kappa-B (NF-κB) and a concomitant increase in its inhibitor (IκB). NFκB is an important cellular transcription regulator for the immune response. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Troglitazone」の詳細全文を読む スポンサード リンク 翻訳と辞書 : 翻訳のためのインターネットリソース Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.